- Home
- CMRX vs PFL Comparison
CMRX vs PFL Comparison
Compare CMRX & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- PFL
- Stock Information
- Founded
- CMRX 2000
- PFL 2003
- Country
- CMRX United States
- PFL United States
- Employees
- CMRX N/A
- PFL N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- CMRX Health Care
- PFL Finance
- Exchange
- CMRX Nasdaq
- PFL Nasdaq
- Market Cap
- CMRX 394.1M
- PFL 329.9M
- IPO Year
- CMRX 2013
- PFL N/A
- Fundamental
- Price
- CMRX $5.15
- PFL $8.48
- Analyst Decision
- CMRX Strong Buy
- PFL
- Analyst Count
- CMRX 2
- PFL 0
- Target Price
- CMRX $8.50
- PFL N/A
- AVG Volume (30 Days)
- CMRX 1.7M
- PFL 113.7K
- Earning Date
- CMRX 03-07-2025
- PFL 01-01-0001
- Dividend Yield
- CMRX N/A
- PFL 11.53%
- EPS Growth
- CMRX N/A
- PFL N/A
- EPS
- CMRX N/A
- PFL N/A
- Revenue
- CMRX $159,000.00
- PFL N/A
- Revenue This Year
- CMRX N/A
- PFL N/A
- Revenue Next Year
- CMRX $1,690.28
- PFL N/A
- P/E Ratio
- CMRX N/A
- PFL N/A
- Revenue Growth
- CMRX N/A
- PFL N/A
- 52 Week Low
- CMRX $0.75
- PFL $6.98
- 52 Week High
- CMRX $5.53
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- CMRX 76.25
- PFL 48.84
- Support Level
- CMRX $3.94
- PFL $8.45
- Resistance Level
- CMRX $5.53
- PFL $8.60
- Average True Range (ATR)
- CMRX 0.30
- PFL 0.05
- MACD
- CMRX 0.07
- PFL -0.00
- Stochastic Oscillator
- CMRX 78.29
- PFL 34.21
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.